Susquehanna Portfolio Strategies, LLC Arcturus Therapeutics Holdings Inc. Transaction History
Susquehanna Portfolio Strategies, LLC
- $6.3 Trillion
- Q3 2025
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 95,914 shares of ARCT stock, worth $697,294. This represents 0.03% of its overall portfolio holdings.
Number of Shares
95,914
Previous 81,177
18.15%
Holding current value
$697,294
Previous $1.06 Billion
67.38%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ARCT
# of Institutions
173Shares Held
26MCall Options Held
2.32MPut Options Held
866K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.95MShares$14.2 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$13.7 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...